Investor and Industry meetings in New York and in Atlanta, USA, June 2018
New issue announcement,
application for quotation of additional securities
Completion of Private Placement ~$7.9M Raised with SPP
We are pleased to release our Quarterly Cashflow report and update for the quarter ending 31 March 2018.
Following an extensive review of the APAS® AI technology in the Company’s facilities in Adelaide and at St Vincent’s Hospital in Melbourne, prestigious German facility Labor Dr Wisplinghoff in Cologne has commissioned its first APAS® Independence instrument. This production-ready instrument has shipped to Germany and will be commissioned by CCS technical staff with scientists at the Labor Dr Wisplinghoff facility, following the ECCMID meeting in Madrid on 21-24 April 2018.
We are pleased to announce that data detailing the performance of the APAS®
Independence in a clinical setting was presented at the ECCMID meeting by Lisa Brenton of St Vincent’s Hospital, Melbourne.